Previous 10 | Next 10 |
GenesisCare Purchases Two Additional ViewRay MRIdian MRI-guided Radiotherapy Systems for Guildford and Birmingham Projects, Doubling United Kingdom Footprint to Four Systems PR Newswire New agreement expands access to precision radiotherapy to more cancer patients in t...
Summary The asymmetry in implied market value has narrowed for ViewRay, with shares looking appropriately priced at current levels. Despite key differentiators in its operating segment, valuations are supportive of a narrow view. Q2 earnings were mixed with plenty of upsides a...
ViewRay ( NASDAQ: VRAY ) said its MRIdian MRI-Guided Radiation Therapy system was approved by China's National Medical Products Administration (NMPA). The approval offers cancer patients a new radiation therapy option, MRIdian Stereotactic MRI-Guided Adaptive Radi...
ViewRay Announces China NMPA Approval of its MRIdian® MRI-Guided Radiation Therapy for Cancer Patients PR Newswire This approval expands MRIdian's global reach and offers cancer patients a new radiation therapy option—MRIdian SMART DENVER , Se...
ViewRay ( NASDAQ: VRAY ) said that the VA Houston Healthcare System has selected a MRIdian MRI-guided radiation therapy system to expand services at the Michael E. DeBakey VA Medical Center. The system will enable the VA Houston Cancer Program to offer advan...
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services PR Newswire This is the First Hospital in Texas and the Third VA Hospital to Offer MRIdian ® MRI-guided Radiation Therapy Cancer Treatment. DENVER , Au...
Kahn Brothers' 13F portfolio value decreased from ~$788M to ~$743M this quarter. New York Community Bancorp, Citigroup, VOXX International, and ViewRay were increased while decreasing Patterson-UTI Energy during the quarter. The portfolio continues to be very concentrated with the...
National Cancer Center Hospital in Tokyo Upgrades to MRIdian® Linac for MRI-Guided Radiation Therapy and has treated its first patients PR Newswire Largest Cancer Center in Japan Enhances its Real-Time Soft-Tissue Tracking and On-Table Adaptive Delivery with M...
ViewRay Selects Denver for Headquarters PR Newswire Innovative cancer therapy company to leverage Colorado bioscience talent resources DENVER , Aug. 8, 2022 /PRNewswire/ -- ViewRay, Inc . (Nasdaq: VRAY), a medical device company that d...
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q2 2022 Earnings Call Aug 02, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q2 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...